You are here

  • Home
  • Archive
  • Volume 9, Issue 7
  • Challenges and next steps in the advancement of immunotherapy: summary of the 2018 and 2020 National Cancer Institute workshops on cell-based immunotherapy for solid tumors

Article info

Article menu
XML
Immune cell therapies and immune cell engineering
Challenges and next steps in the advancement of immunotherapy: summary of the 2018 and 2020 National Cancer Institute workshops on cell-based immunotherapy for solid tumors

Authors

  • Laura K Fogli ImmunoOncology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland, USA PubMed articlesGoogle scholar articles
  • Rosemarie Aurigemma Office of the Associate Director, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland, USA PubMed articlesGoogle scholar articles
  • Connie L Sommers ImmunoOncology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland, USA PubMed articlesGoogle scholar articles
  • Anju Singh ImmunoOncology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland, USA PubMed articlesGoogle scholar articles
  • Kasia Bourcier ImmunoOncology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland, USA PubMed articlesGoogle scholar articles
  • Marc S Ernstoff ImmunoOncology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland, USA PubMed articlesGoogle scholar articles
  • on Behalf of the NCI Cell Therapy Workshop Committee
    Google scholar articles

Citation

Fogli LK, Aurigemma R, Sommers CL on Behalf of the NCI Cell Therapy Workshop Committee, et al
Challenges and next steps in the advancement of immunotherapy: summary of the 2018 and 2020 National Cancer Institute workshops on cell-based immunotherapy for solid tumors
Journal for ImmunoTherapy of Cancer 2021;9:e003048. doi: 10.1136/jitc-2021-003048
Online issue publication 
November 02, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/.